Algernon Receives Clearance From Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has received a “No Objection” letter from Health Canada... Read More